1. Latest News
  2. Submit Press Release
Cambridge Healthtech Institute Logo

James E. Bradner, M.D. added as keynote to CHI's Inaugural Chemical Biology for Target Validation

This event is being held May 22-23, 2014 at the Westin Boston Waterfront, in Boston, Massachusetts

PRLog - Feb. 18, 2014 - NEEDHAM, Mass. -- Genome-Wide Spatial Localization of Small Molecules
James E. Bradner, M.D., Assistant Professor, Department of Medicine, Harvard Medical School and Investigator, Department of Medical Oncology, Dana-Farber Cancer Institute

Other Keynotes include:

Selecting and Modulating Therapeutic Targets Using Human Biology and Chemical Biology
Stuart L. Schreiber, Ph.D., Director, Chemical Biology, Founding Member, Broad Institute of Harvard and MIT; Howard Hughes Medical Institute Investigator; Morris Loeb Professor, Chemistry and Chemical Biology, Harvard University

Structures, Chemical Probes, New Biology, New Targets for Drug Discovery: Is This the Right Sequence?
Chas Bountra, Ph.D., Professor, Translational Medicine; Head, Structural Genomics Consortium, University of Oxford

Covalent Inhibitors of Oncogenic Signaling Pathways
Nathanael Gray, Ph.D., Professor, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Professor, Cancer Biology, Dana-Farber Cancer Institute

For more information or to register please visit: http://www.healthtech.com/Target-Validation/

Richard Handy

--- End ---

Click to Share

Contact Email:
Source:Cambridge Healthtech Institute
Location:Needham - Massachusetts - United States
Industry:Biotech, Science
Tags:target validation, Chemical Biology, drug discovery, Target_Phenotype, small-molecule
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share